-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Surgery Partners, Lowers Price Target to $20

Benzinga·03/05/2026 18:14:42
Listen to the news
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $28 to $20.